SE446406B - Nya foreningar med karcinostatisk och immunostimulerande verkan framstellda genom odling av fusobacterium nucleatum tf-031(ferm 5077, atcc 31647), forfarande for framstellning av desamma och karcinostatiskt medel inneha - Google Patents

Nya foreningar med karcinostatisk och immunostimulerande verkan framstellda genom odling av fusobacterium nucleatum tf-031(ferm 5077, atcc 31647), forfarande for framstellning av desamma och karcinostatiskt medel inneha

Info

Publication number
SE446406B
SE446406B SE8005921A SE8005921A SE446406B SE 446406 B SE446406 B SE 446406B SE 8005921 A SE8005921 A SE 8005921A SE 8005921 A SE8005921 A SE 8005921A SE 446406 B SE446406 B SE 446406B
Authority
SE
Sweden
Prior art keywords
phosphate buffer
sulfuric acid
reaction
sodium chloride
fraction
Prior art date
Application number
SE8005921A
Other languages
English (en)
Swedish (sv)
Other versions
SE8005921L (sv
Inventor
K Tamai
I Saikawa
T Yasuda
S Murakami
T Maeda
H Tsuda
H Sakai
M Sugita
Y Yamamoto
H Minami
T Hori
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10781979A external-priority patent/JPS5645496A/ja
Priority claimed from JP10781479A external-priority patent/JPS5630995A/ja
Priority claimed from JP10781879A external-priority patent/JPS5630997A/ja
Priority claimed from JP10781779A external-priority patent/JPS5630996A/ja
Priority claimed from JP10812080A external-priority patent/JPS5732293A/ja
Priority claimed from JP10812280A external-priority patent/JPS5732295A/ja
Priority claimed from JP10812480A external-priority patent/JPS5732297A/ja
Priority claimed from JP10812380A external-priority patent/JPS5732296A/ja
Priority claimed from JP10812180A external-priority patent/JPS5732294A/ja
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of SE8005921L publication Critical patent/SE8005921L/xx
Publication of SE446406B publication Critical patent/SE446406B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8005921A 1979-08-24 1980-08-22 Nya foreningar med karcinostatisk och immunostimulerande verkan framstellda genom odling av fusobacterium nucleatum tf-031(ferm 5077, atcc 31647), forfarande for framstellning av desamma och karcinostatiskt medel inneha SE446406B (sv)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP10781979A JPS5645496A (en) 1979-08-24 1979-08-24 Carcinostatic substance, tf-130, its preparation and carcinostatic preparation containing the same
JP10781479A JPS5630995A (en) 1979-08-24 1979-08-24 Carcinostatic substance tf-100, its preparation, and carcinostatic comprizing it
JP10781879A JPS5630997A (en) 1979-08-24 1979-08-24 Carcinostatic substance tf-120, its preparation, and carcinostatic comprizing it
JP10781779A JPS5630996A (en) 1979-08-24 1979-08-24 Carcinostatic substance tf-110, its preparation, and carcinostatic comprizing it
JP10812080A JPS5732293A (en) 1980-08-06 1980-08-06 Carcinostatic substance tf-132b, its preparation, and carcinostatic agent containing the same
JP10812280A JPS5732295A (en) 1980-08-06 1980-08-06 Carcinostatic substance tf-1323, its preparation, and carcinostatic agent containing the same
JP10812480A JPS5732297A (en) 1980-08-06 1980-08-06 Carcinostatic substance tf-150, its preparation, and carcinostatic agent containing the same
JP10812380A JPS5732296A (en) 1980-08-06 1980-08-06 Carcinostatic substance tf-140, its preparation, and carcinostatic agent containing the same
JP10812180A JPS5732294A (en) 1980-08-06 1980-08-06 Carcinostatic substance tf-133b, its preparation, and carcinostatic agent containing the same

Publications (2)

Publication Number Publication Date
SE8005921L SE8005921L (sv) 1981-02-25
SE446406B true SE446406B (sv) 1986-09-08

Family

ID=27577343

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8005921A SE446406B (sv) 1979-08-24 1980-08-22 Nya foreningar med karcinostatisk och immunostimulerande verkan framstellda genom odling av fusobacterium nucleatum tf-031(ferm 5077, atcc 31647), forfarande for framstellning av desamma och karcinostatiskt medel inneha

Country Status (15)

Country Link
AT (1) AT375674B (nl)
AU (1) AU529076B2 (nl)
CA (1) CA1174618A (nl)
CH (1) CH648042A5 (nl)
DE (1) DE3031152A1 (nl)
DK (1) DK151639C (nl)
FI (1) FI68080C (nl)
FR (1) FR2463619A1 (nl)
GB (1) GB2059969B (nl)
IT (1) IT1181595B (nl)
NL (1) NL8004759A (nl)
NO (1) NO155697C (nl)
NZ (1) NZ194744A (nl)
PT (1) PT71730A (nl)
SE (1) SE446406B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2093347B (en) * 1981-02-19 1985-03-27 Toyama Chemical Co Ltd Immunostimulant material tf-2 from fusobacterium sp
AU572529B2 (en) * 1983-08-01 1988-05-12 Furukawa, Keiichiro Spf-100 and process for the preparation thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58318B2 (ja) * 1977-07-11 1983-01-06 住友化学工業株式会社 制癌性物質の製造方法

Also Published As

Publication number Publication date
AU6164680A (en) 1981-04-09
IT1181595B (it) 1987-09-30
DK361680A (da) 1981-02-25
AT375674B (de) 1984-08-27
IT8049541A0 (it) 1980-08-22
AU529076B2 (en) 1983-05-26
CA1174618A (en) 1984-09-18
DK151639C (da) 1988-06-20
PT71730A (en) 1980-09-01
NZ194744A (en) 1984-05-31
DK151639B (da) 1987-12-21
FR2463619B1 (nl) 1984-11-30
SE8005921L (sv) 1981-02-25
NO155697B (no) 1987-02-02
NO155697C (no) 1987-05-13
GB2059969B (en) 1983-05-18
NO802499L (no) 1981-02-25
NL8004759A (nl) 1981-02-26
FI68080B (fi) 1985-03-29
DE3031152A1 (de) 1981-03-19
DE3031152C2 (nl) 1989-08-03
FR2463619A1 (fr) 1981-02-27
CH648042A5 (de) 1985-02-28
ATA426480A (de) 1984-01-15
FI68080C (fi) 1985-07-10
FI802641A (fi) 1981-02-25
GB2059969A (en) 1981-04-29

Similar Documents

Publication Publication Date Title
Wessler The nature of the non-ultrafilterable glycosaminoglycans of normal human urine
Muramatsu et al. Characterization of glycopeptides isolated from membranes of F9 embryonal carcinoma cells
JP4043533B2 (ja) 低分子量リポポリサッカライド
JPS5896025A (ja) 新規生理活性物質ｃｈ−１およびその製造法
Volk Quantitative assay of polysaccharide components obtained from cell wall lipopolysaccharides of Xanthomonas species
US20190002596A1 (en) Sulfated heparin oligosaccharide and preparation method and application thereof
Kaplan et al. Studies on the turnover of plasma membranes in cultured mammalian cells.: II. Rates of synthesis and degradation of plasma membrane proteins and carbohydrates
WO1990003791A1 (en) Methods for interfering with hiv multiplication and composition for the treatment of aids
Vos et al. Distribution of acid mucopolysaccharides in subcellular fractions of mouse brain
SE446406B (sv) Nya foreningar med karcinostatisk och immunostimulerande verkan framstellda genom odling av fusobacterium nucleatum tf-031(ferm 5077, atcc 31647), forfarande for framstellning av desamma och karcinostatiskt medel inneha
US4744985A (en) Novel substances having carcinostatic and immunostimulating activity, process for preparing the same and carcinostatic agent containing the same
US3334022A (en) Neocarzinostatin produced by streptomyces carzinost aticus var. neocarzinostaticus
Sisson Stimulation of glucose utilization and glycosaminoglycans production by fibroblasts derived from retrobulbar tissue
US4547462A (en) Process for preparing substance having carcinostatic and immunostimulating activity
Huey et al. Hyaluronic acid determinations: Optimizing assay parameters
US4477437A (en) Substances having carcinostatic and immunostimulating activity
US3629235A (en) Process for isolating an interferon inducer and the product per se
EP0496351B1 (en) Acid heteropolysaccharide, sulfated polysaccharide and process for producing the same
AU2020103108A4 (en) Prawn head heparinoid, preparation method thereof, and use thereof in preparation of anticoagulant
CA1184864A (en) Substances having carcinostatic and immunostimulating activity, process for preparing the same and carcinostatic agent containing the same
CN116675784A (zh) 具有α-葡萄糖苷酶抑制作用的牡蛎糖胺聚糖及制备方法
US3718741A (en) N-1 and N-2 FRACTIONS OF NEOCARZIONSTATIN
US3870698A (en) Quintomycin compounds
Armand et al. Isolation and characterization of ichthyosan from tuna vitreous
CN114230682A (zh) 一种功能性香蕉多糖bpf2及其制备与应用

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8005921-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8005921-5

Format of ref document f/p: F